Patent · US Active

Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

US8101601B2 · kind B2 · utility

5Cited by

0References

4Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Hans-Georg Lerchen · Leverkusen, DE
Ursula Krenz · Leichlingen, DE
Karl-Heinz Schlemmer · Wuppertal, DE
Elisabeth Perzborn · Wuppertal, DE
Joerg Keldenich · Wuppertal, DE

Key dates

Filing date	Feb 6, 2007
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Jul 15, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.